High Order Diffusion Tensor Imaging in Human Glioblastoma

Academic Radiology

Volumn 18, Issue 8, 2011, Pages 947-954

  Ellingson, Benjamin M ^a   Cloughesy, Timothy F ^a   Lai, Albert ^a   Nghiemphu, Phioanh L ^a   Liau, Linda M ^a   Pope, Whitney B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain tumor; Diffusion MRI; DTI; Fourth order tensor; GBM; Glioblastoma

Indexed keywords

ARTICLE; BRAIN TUMOR; CANCER INVASION; CELL HETEROGENEITY; CELL INFILTRATION; CELL INVASION; CLINICAL ARTICLE; COMPARATIVE STUDY; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; GLIOBLASTOMA; HUMAN; MALE; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TUMOR VOLUME; WHITE MATTER;

ANALYSIS OF VARIANCE; ANISOTROPY; BRAIN NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOBLASTOMA; HUMANS; MALE; NEOPLASM INVASIVENESS;

EID: 79959747117     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.02.020     Document Type: Article

References (29)

1. Pavlisa G., Rados M., Pavlisa G., et al. The differences of water diffusion between brain tissue infiltrated by tumor and peritumoral vasogenic edema. Clin Imaging 2009, 33:96-101.
2. McMillan K.M., Rogers B.P., Field A.S., et al. Physiologic characterisation of glioblastoma multiforme using MRI-based hypoxia mapping, chemical shift imaging, perfusion and diffusion maps. J Clin Neurosci 2006, 13:811-817.
3. Chenevert T.L., Stegman L.D., Taylor J.M., et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000, 92:2029-2036.
4. Ellingson B.M., Malkin M.G., Rand S.D., et al. Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. J Magn Reson Imaging 2010, 31:538-548.
5. Lu S., Ahn D., Johnson G., et al. Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 2004, 232:221-228.
6. Gerstner E.R., Chen P.J., Wen P.Y., et al. Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib. Neuro Oncol 2010, 12:466-472.
7. Pope W.B., Kim H.J., Huo J., et al. Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment. Radiology 2009, 252:182-189.
8. Khayal I.S., Polley M.Y., Jalbert L., et al. Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme. Neuro Oncol 2010, 12:908-916.
9. Ellingson B.M., Malkin M.G., Rand S.D., et al. Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas. J Neurooncol 2011, 102:95-103.
10. Jakab A, Molnar P, Emri M, et al. Glioma grade assessment by using histogram analysis of diffusion tensor imaging-derived maps. Neuroradiology. In press.
11. Basser P.J., Pajevic S., Pierpaoli C., et al. In vivo fiber tractography using DT-MRI data. Magn Reson Med 2000, 44:625-632.
12. Ferda J., Kastner J., Mukensnabl P., et al. Diffusion tensor magnetic resonance imaging of glial brain tumors. Eur J Radiol 2010, 74:428-436.
13. Byrnes T.J., Barrick T.R., Bell B.A., et al. Diffusion tensor imaging discriminates between glioblastoma and cerebral metastases in vivo. NMR Biomed 2011, 24:54-60.
14. Saksena S., Jain R.K., Narang J., et al. Predicting survival in glioblastoma using diffusion tensor imaging metrics. J Magn Reson Imaging 2010, 32:788-795.
15. Kleiser R., Staempfil P., Valavanis A., et al. Impact of fMRI-guided advanced DTI fiber tracking techniques on their clinical applications in patients with brain tumors. Neuroradiology 2010, 52:37-46.
16. Wu J.S., Zhou L.F., Tang W.J., et al. Clinical evaluation and follow-up outcome of diffusion tensor imaging-based functional neuronavigation: a prospective, controlled study in patients with gliomas involving pyramidal tracts. Neurosurgery 2007, 61:935-948.
17. Basser P.J., Mattiello J., LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994, 66:259-267.
18. Basser P.J., Pajevic S. Spectral decomposition of a 4th-order covariance tensor: applications to diffusion tensor MRI. Signal Process 2007, 87:220-236.
19. Tuch D.S., Reese T.G., Wiegell M.R., et al. Diffusion MRI of complex neural architecture. Neuron 2003, 40:885-895.
20. Jayachandra M.R., Rehbein N., Herweh C., et al. Fiber tracking of human brain using fourth-order tensor and high angular resolution diffusion imaging. Magn Reson Med 2008, 60:1207-1217.
21. Reese T.G., Heid O., Weisskoff R.M., et al. Reduction of eddy-current-induced distortion in diffusion MRI using a twice-refocused spin echo. Magn Reson Med 2003, 49:177-182.
22. Basser P.J. New histological and physiological stains derived from diffusion-tensor MR images. Ann N Y Acad Sci 1997, 820:123-138.
23. Barmpoutis A., Hwang M.S., Howland D., et al. Regularized positive-definite fourth order tensor field estimation from DW-MRI. Neuroimage 2009, 45:S153-S162.
24. Barmpoutis A., Jian B., Vemuri B.C., et al. Symmetric positive 4th order tensors & their estimation from diffusion weighted MRI. Inf Process Med Imaging 2007, 20:308-319.
25. Ozarslan E., Vemuri B.C., Mareci T.H. Generalized scalar measures for diffusion MRI using trace, variance, and entropy. Magn Reson Med 2005, 53:866-876.
26. Goebell E., Paustenbach S., Vaeterlein O., et al. Low-grade and anaplastic gliomas: differences in architecture evaluated with diffusion-tensor MR imaging. Radiology 2006, 239:217-222.
27. Provenzale J.M., McGraw P., Mhatre P., et al. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 2004, 232:451-460.
28. Price S.J., Burnet N.G., Donovan T., et al. Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion?. Clin Radiol 2003, 58:455-462.
29. Stecco A., Pisani C., Quarta R., et al. DTI and PWI analysis of peri-enhancing tumoral brain tissue in patients treated for glioblastoma. J Neurooncol 2010, 102:261-271.